Pleased to have contributed to this review on FTD and the differential diagnoses, from a real-world quaternary memory clinic. Have a listen to this podcast with Prof Brodtmann:
Neurology Podcast: Dr. Trey Bateman and Dr. Amy Brodtmann discuss the complexities of diagnosing FTD and related disorders. Listen now: https://t.co/CYdN1o5d99
#NeuroTwitter#Dementia@RenegadeSynapse
💫Thank you to everyone for sharing their time, expertise and experience of #PD for the NEW 🌟PARKINSONS MOOC 🌟Together we can improve understanding and education 🙂@MicheleCallisa1 @predictPD@WickingDementia@ParkinsonsAus@MichaelOkun@basbloem https://t.co/UPDo2FX98B
Calling all Victorians from #Chinese backgrounds!
We are recruiting participants for a new 8-week program called 'Befriending with GENIE' which aims to reduce #loneliness & increase #SocialSupport by connecting you with a friendly person to talk to and provide helpful resources.
Spitz et al. study long-term survivors of moderate-severe TBI, and show that elevated plasma levels of biomarkers related to neuronal damage are associated with white matter microstructure disruption on MRI and disordered cognition. https://t.co/DFD5meGDr6
Pleased to present our paper @eBioMedicine, on the Lumipulse plasma pTau217 assay.
Lumipulse-G platform → large global installation base in clinical pathology services → better access/uptake of plasma #ptau217 into clinical practice.
Link: https://t.co/dZaIRfJPL2
#Alzheimers
We at Rowe Lab are very proud that our PET expert, @vincentDore2 was awarded the prestigious de Leon Prize, as senior author of “CenTauR: Toward a universal scale and masks for standardizing tau imaging studies”. Time to celebrate this great achievement! #AAIC24#AIC
Quantitative tau PET and tau PET visual reads show the greatest promise as a stand-alone prognostic marker for clinical progression to dementia among individuals with MCI, outperforming Aβ PET and MRI. https://t.co/lznaW2xL4e
Excited to attend the Australian Dementia Research Forum, virtually! #ADRF - here's to conferences that are continuing with a hybrid format @ADNeT_Australia@Momademia
Not long to go now! Don't forget to register for this unique opportunity to meet Prof Lautenschlager and likeminded researchers in #Neuroscience#Alzheimers hosted by @DrKaramacoska and @ISTAART
Is there clinical evidence for the use of GLP-1 receptor agonists in #Alzheimers disease? Our recent systematic review suggests current data is limited, but upcoming RCT's may yield more insights: https://t.co/xXmCYxTxtn #ADresearch@vincentDore2@RoweLab_aus
So excited and grateful to be the plenary speaker for the @NeuroimagingPIA year in review talk 🧠 at AIC 2024 in Philadelphia this July!🤩 @alzassociation#AAIC24
🎖️ Please help me compile the most inspiring papers of the year via this survey:
📨 https://t.co/Cil3GzsVGu
We want to know about gaps, barriers+opportunities for #YOD.
Please complete our surveys+repost!
People living with YOD https://t.co/Co5G2ba9yi
Carers https://t.co/4C6bPSmtTf
Clinicians https://t.co/XUTip1siKJ
Services/NDIS https://t.co/xD6RfuTgMC
GPs https://t.co/tilrqv8vWN
🌟 Don't miss out! 🌟 Sign up now for the Mentoring Club session 📚✨ on May 29 hosted by @PEERSPIA and @ISTAART. Register at https://t.co/5z6jmBI2yM to attend!